Remove 2007 Remove Compounding Remove FDA
article thumbnail

CDC Report Finds No Connection Between Thimerosal and Autism

Drug Topics

Thimerosal is a mercury-containing compound that has been widely used as a preservative in some biological and drug products since the 1930s. 1,2 Thimerosal is a mercury-containing compound that has been widely used as a preservative in some biological and drug products since the 1930s.

article thumbnail

From Pasteur to Present: Historical and Contemporary Perspectives on Publication Bias in Scientific Literature

Pharmacy Times

According to findings of a study cited by Joober et al, the frequency of papers declaring significant statistical support for their a priori formulated hypotheses increased by 22% between 1990 and 2007 (n = 4656; P < 001).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Evaluating NMR relaxometry for antibody identification

European Pharmaceutical Review

NMR relaxation methods distinguish between components (phases or compounds) that have different molecular mobilities For monoclonal antibodies, identification methodologies can employ chromatography, spectroscopy, isoelectric focusing, capillary electrophoresis and peptide mapping techniques. 2007; 66(11-12): 963–8. Cited 2023Feb].

article thumbnail

Low Dose Naltrexone and Hashimoto’s

The Thyroid Pharmacist

You may be familiar with naltrexone, which is an FDA-approved medication that has been used since the 1980s for opioid withdrawal. The first article was published in 2007, and it showed LDN as an effective and safe therapy for Crohn’s disease. [4] It needs to be compounded into lower doses by a professional compounding pharmacy.

article thumbnail

Company profile: NeoImmuneTech

pharmaphorum

By enabling strong CD8 T-cell infiltration in cold tumor tissues, NT-I7, a compound developed by NeoImmuneTech, is capable of promoting a microenvironment that contributes to clinical efficacy, when combined with a CPI. Amplifying and reinvigorating persistent T cell immunity has become a much-needed path to enhance anti-tumor efficacy.

article thumbnail

Could SIBO Be Preventing Your Remission from Hashimoto’s?

The Thyroid Pharmacist

In fact, a 2007 study found that about 50 percent of people with hypothyroidism have SIBO, while a 2017 study found that levothyroxine use can contribute to the development of SIBO! Please note, Integrative Therapeutics has removed distribution of this formula from retail channels, as it is an FDA-regulated medical food.

article thumbnail

Solutions for Constipation Relief

The Thyroid Pharmacist

Plecanatide : This is one of the newest medications for IBS-C that has been approved by the FDA. Tenapanor : Tenapanor was approved by the FDA in September of 2019 for IBS-C. Tegaserod : This medication was approved for IBS-C in 2002, but removed from the market in 2007 due to an increased risk of cardiovascular events.